Vanda Pharma Secures USFDA Nod for Bysanti to Treat Schizophrenia, Acute Bipolar I
Bengaluru: The U.S. Food and Drug Administration (USFDA) has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health conditions, the company said on Friday.The drug, branded as…